FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.12  |  FHIR Version n/a  User: [n/a]

445522003: Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet (clinical drug)

Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jul 2018. Module: SNOMED CT core module

Descriptions:

Id Description Lang Type Status Case? Module
3502290014 Rifaximin 550 mg oral tablet en Synonym Active Entire term case insensitive SNOMED CT core module
3682679014 Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet (clinical drug) en Fully specified name Active Entire term case insensitive SNOMED CT core module
68935201000001117 Rifaximin 550mg tablets en Synonym Active Only initial character case insensitive SNOMED CT United Kingdom Edition module

5 descendants. Search Descendants:

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Is a Product manufactured as oral dose form false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Is a Product containing rifaximin false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has active ingredient Rifaximin false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has active ingredient Rifaximin false Inferred relationship Existential restriction modifier 1
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has basis of strength substance Rifaximin true Inferred relationship Existential restriction modifier 1
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has presentation strength numerator value 550 false Inferred relationship Existential restriction modifier 1
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has presentation strength numerator unit milligram true Inferred relationship Existential restriction modifier 1
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has presentation strength denominator value 1 false Inferred relationship Existential restriction modifier 1
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has presentation strength denominator unit Tablet true Inferred relationship Existential restriction modifier 1
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has precise active ingredient Rifaximin true Inferred relationship Existential restriction modifier 1
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Is a Product containing rifaximin in oral dose form (medicinal product form) false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Is a Product containing only rifaximin in oral dose form (medicinal product form) true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Plays role Antibacterial therapeutic role true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Is a Rifaximin true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) route of administration Oral route true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) VMP (Virtual Medicinal Product) ontology form and route tablet.oral ontology form and route true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) dose form indicator Discrete dose form indicator true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has NHS dm+d (dictionary of medicines and devices) controlled drug category Controlled drug category No Controlled Drug Status true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has manufactured dose form Oral dose form true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has active ingredient Rifaximin false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has manufactured dose form Conventional release oral tablet false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has unit of presentation Tablet false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Count of base of active ingredient 1 false Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Is a Virtual medicinal product true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has specific active ingredient Rifaximin true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet VMP prescribing status (attribute) VMP valid as a prescribable product true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet VMP non-availability indicator Available true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has dispensed dose form Tablet true Inferred relationship Existential restriction modifier
Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Has manufactured dose form Tablet false Inferred relationship Existential restriction modifier
Inbound Relationships Type Active Source Characteristic Refinability Group
Targaxan 550mg tablets (CST Pharma Ltd) Is a True Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Pilsco Ltd) Is a True Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Xifaxan 550mg tablets (Imported (United States)) Is a True Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Rifaximin 550mg tablets (Special Order) Is a True Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Rifaximin 550mg tablets 1 tablet Has VMP True Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Rifaximin 550mg tablets 60 tablet Has VMP True Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Targaxan 550mg tablets (Norgine Pharmaceuticals Ltd) Is a True Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier
Rifaximin 550mg tablets 56 tablet Has VMP True Product containing precisely rifaximin 550 milligram/1 each conventional release oral tablet Inferred relationship Existential restriction modifier

This concept is not in any reference sets

Back to Start